OrthoPediatrics’ (KIDS) “Buy” Rating Reaffirmed at Needham & Company LLC

Needham & Company LLC reissued their buy rating on shares of OrthoPediatrics (NASDAQ:KIDS) in a research note issued to investors on Friday, Benzinga reports. Needham & Company LLC currently has a $42.00 target price on the stock.

Separately, Truist Financial reissued a hold rating and issued a $30.00 price target (down from $35.00) on shares of OrthoPediatrics in a report on Thursday, August 8th.

OrthoPediatrics Trading Up 2.2 %

OrthoPediatrics stock opened at $32.28 on Friday. OrthoPediatrics has a 12-month low of $23.10 and a 12-month high of $36.23. The company has a debt-to-equity ratio of 0.03, a current ratio of 4.90 and a quick ratio of 1.96. The stock has a market capitalization of $781.50 million, a PE ratio of -34.29 and a beta of 1.18. The firm has a 50 day simple moving average of $30.81 and a 200-day simple moving average of $30.10.

OrthoPediatrics (NASDAQ:KIDS) last issued its quarterly earnings results on Monday, August 5th. The company reported ($0.23) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.31) by $0.08. OrthoPediatrics had a negative return on equity of 5.44% and a negative net margin of 14.35%. The firm had revenue of $52.80 million during the quarter, compared to analyst estimates of $52.40 million. As a group, equities research analysts expect that OrthoPediatrics will post -0.96 EPS for the current fiscal year.

Insider Activity

In other OrthoPediatrics news, General Counsel Daniel J. Gerritzen sold 10,000 shares of the business’s stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $29.30, for a total transaction of $293,000.00. Following the sale, the general counsel now owns 77,304 shares in the company, valued at approximately $2,265,007.20. The transaction was disclosed in a filing with the SEC, which is available through this link. 31.80% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On OrthoPediatrics

A number of large investors have recently made changes to their positions in KIDS. Quest Partners LLC purchased a new position in OrthoPediatrics during the 2nd quarter worth approximately $34,000. EntryPoint Capital LLC grew its holdings in shares of OrthoPediatrics by 56.9% during the first quarter. EntryPoint Capital LLC now owns 2,783 shares of the company’s stock valued at $81,000 after buying an additional 1,009 shares in the last quarter. SG Americas Securities LLC acquired a new position in OrthoPediatrics during the second quarter valued at $110,000. State Board of Administration of Florida Retirement System purchased a new stake in OrthoPediatrics in the 1st quarter worth about $178,000. Finally, Deerfield Management Company L.P. Series C acquired a new stake in OrthoPediatrics during the 2nd quarter worth about $203,000. Institutional investors and hedge funds own 69.05% of the company’s stock.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.